Focal Therapy (FT) for Prostate Cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in selecting, treating and following up men undergoing FT, though there is limited evidence in this field to guide practice. We aimed to conduct a consensus meeting, endorsed by the Focal Therapy Society, amongst a large group of experts, to understand the potential utility of MB in FT for localised PCa.
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society / Marra, Giancarlo; Laguna, Maria Pilar; Walz, Jochen; Pavlovich, Christian P; Bianco, Fernando; Gregg, Justin; Lebastchi, Amir H; Lepor, Herbert; Macek, Petr; Rais-Bahrami, Soroush; Robertson, Cary; Rukstalis, Daniel; Salomon, Georg; Ukimura, Osamu; Abreu, Andre L; Barbe, Yann; Cathelineau, Xavier; Gandaglia, Giorgio; George, Arvin K; Rivas, Juan Gomez; T Gupta, Rajan; Lawrentschuk, Nathan; Kasivisvanathan, Veeru; Lomas, Derek; Malavaud, Bernard; Margolis, Daniel; Matsuoka, Yoh; Mehralivand, Sherif; Moschini, Marco; Oderda, Marco; Orabi, Hazem; Rastinehad, Ardeshir R; Remzi, Mesut; Schulman, Ariel; Shin, Toshitaka; Shiraishi, Takumi; Sidana, Abhinav; Shoji, Sunao; Stabile, Armando; Valerio, Massimo; Tammisetti, Varaha S; Tan, Wei Phin; Van Den Bos, Willemien; Villers, Arnaud; Willemse, Peter-Paul; de la Rosette, Jean; Polascik, Thomas; Sanchez-Salas, Rafael; Focal therapy Soc Collaboration, Group. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 1827-1758. - 74:5(2022), pp. 581-589. [10.23736/S2724-6051.20.04160-0]
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society
Gandaglia, Giorgio;Stabile, Armando;
2022-01-01
Abstract
Focal Therapy (FT) for Prostate Cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in selecting, treating and following up men undergoing FT, though there is limited evidence in this field to guide practice. We aimed to conduct a consensus meeting, endorsed by the Focal Therapy Society, amongst a large group of experts, to understand the potential utility of MB in FT for localised PCa.| File | Dimensione | Formato | |
|---|---|---|---|
|
R19Y2022N05A0581.pdf
solo gestori archivio
Tipologia:
Submitted manuscript (manoscritto inviato all’editore)
Licenza:
Copyright dell'editore
Dimensione
1.04 MB
Formato
Adobe PDF
|
1.04 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
